Symbols / VRPX $0.00 +0.00% Virpax Pharmaceuticals, Inc.

Healthcare • Biotechnology • United States • PNK
VRPX Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country PNK · United States
Market Cap 621.00
Enterprise Value —
Income —
Sales —
FCF (ttm) —
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) —
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand —
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $0.00
Price $0.00
Change 0.00%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
12.08
-28.69%
16.94
-22.46%
21.85
+81.66%
12.03
Research And Development
5.82
+13.71%
5.12
-52.45%
10.76
+122.41%
4.84
Selling General And Administration
6.26
-47.04%
11.82
+6.67%
11.08
+54.21%
7.19
General And Administrative Expense
6.26
-47.04%
11.82
+6.67%
11.08
+54.21%
7.19
Salaries And Wages
—
0.34
—
—
Other Gand A
6.26
-45.50%
11.49
+3.65%
11.08
+54.21%
7.19
Total Expenses
12.08
-28.69%
16.94
-22.46%
21.85
+81.66%
12.03
Operating Income
-12.08
+28.69%
-16.94
+22.46%
-21.85
-81.66%
-12.03
Total Operating Income As Reported
-12.08
+23.01%
-15.69
+28.18%
-21.85
-81.66%
-12.03
EBITDA
-11.96
+29.38%
-16.94
+22.46%
-21.85
-82.60%
-11.96
Normalized EBITDA
-11.96
+34.23%
-18.19
+16.73%
-21.85
-82.60%
-11.96
EBIT
-11.96
+29.38%
-16.94
+22.46%
-21.85
-82.60%
-11.96
Total Unusual Items
—
1.25
—
—
Total Unusual Items Excluding Goodwill
—
1.25
—
—
Special Income Charges
—
1.25
—
—
Other Special Charges
—
-1.25
—
—
Net Income
-12.07
+20.56%
-15.19
+29.84%
-21.65
-79.58%
-12.06
Pretax Income
-12.07
+20.56%
-15.19
+29.84%
-21.65
-79.58%
-12.06
Net Non Operating Interest Income Expense
-0.10
—
0.00
+100.00%
-0.09
Interest Expense Non Operating
0.10
—
0.00
-100.00%
0.09
Net Interest Income
-0.10
—
0.00
+100.00%
-0.09
Interest Expense
0.10
—
0.00
-100.00%
0.09
Other Income Expense
0.12
-93.35%
1.75
+800.29%
0.19
+212.26%
0.06
Other Non Operating Income Expenses
0.12
-76.72%
0.50
+157.33%
0.19
+212.26%
0.06
Tax Provision
—
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-12.07
+20.56%
-15.19
+29.84%
-21.65
-79.58%
-12.06
Net Income From Continuing Operation Net Minority Interest
-12.07
+20.56%
-15.19
+29.84%
-21.65
-79.58%
-12.06
Net Income From Continuing And Discontinued Operation
-12.07
+20.56%
-15.19
+29.84%
-21.65
-79.58%
-12.06
Net Income Continuous Operations
-12.07
+20.56%
-15.19
+29.84%
-21.65
-79.58%
-12.06
Normalized Income
-12.07
+26.60%
-16.44
+24.07%
-21.65
-79.58%
-12.06
Net Income Common Stockholders
-12.07
+20.56%
-15.19
+29.84%
-21.65
-79.58%
-12.06
Diluted EPS
—
-324.25
+29.89%
-462.50
-2.21%
-452.50
Basic EPS
—
-324.25
+29.89%
-462.50
-2.21%
-452.50
Basic Average Shares
—
0.05
+0.00%
0.05
+75.40%
0.03
Diluted Average Shares
—
0.05
+0.00%
0.05
+75.40%
0.03
Diluted NI Availto Com Stockholders
-12.07
+20.56%
-15.19
+29.84%
-21.65
-79.58%
-12.06
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
1.56
-83.84%
9.63
-51.06%
19.67
-50.28%
39.57
Current Assets
1.56
-83.84%
9.63
-51.06%
19.67
-50.28%
39.57
Cash Cash Equivalents And Short Term Investments
1.51
-83.45%
9.14
-51.87%
19.00
-48.44%
36.84
Cash And Cash Equivalents
1.51
-83.45%
9.14
-51.87%
19.00
-48.44%
36.84
Cash Financial
1.51
-83.45%
9.14
-51.87%
19.00
-48.44%
36.84
Prepaid Assets
0.00
-98.89%
0.42
-35.74%
0.65
+155.24%
0.26
Current Deferred Assets
0.00
0.00
—
—
Other Current Assets
0.03
-48.18%
0.07
+165.27%
0.03
-98.98%
2.47
Total Non Current Assets
0.00
0.00
0.00
0.00
Non Current Deferred Assets
—
—
—
0.00
Total Liabilities Net Minority Interest
2.47
-67.91%
7.69
+148.63%
3.09
+48.23%
2.09
Current Liabilities
2.47
-67.91%
7.69
+148.63%
3.09
+48.23%
2.09
Payables And Accrued Expenses
2.47
+45.77%
1.69
+54.76%
1.09
-47.57%
2.09
Payables
0.04
+122.44%
0.02
-50.97%
0.04
+89.73%
0.02
Other Payable
0.04
+122.44%
0.02
-50.97%
0.04
+89.73%
0.02
Current Accrued Expenses
2.43
+44.93%
1.68
+58.53%
1.06
-48.89%
2.07
Total Tax Payable
—
—
—
0.01
Current Deferred Liabilities
—
—
—
0.00
Other Current Liabilities
—
6.00
+200.00%
2.00
—
Total Non Current Liabilities Net Minority Interest
0.00
0.00
0.00
0.00
Stockholders Equity
-0.91
-147.24%
1.93
-88.33%
16.58
-55.77%
37.48
Common Stock Equity
-0.91
-147.24%
1.93
-88.33%
16.58
-55.77%
37.48
Capital Stock
0.00
+1141.67%
0.00
+0.00%
0.00
-89.74%
0.00
Common Stock
0.00
+1141.67%
0.00
+0.00%
0.00
-89.74%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
0.60
+1171.11%
0.05
-0.02%
0.05
0.00%
0.05
Ordinary Shares Number
0.60
+1171.11%
0.05
-0.02%
0.05
0.00%
0.05
Additional Paid In Capital
70.70
+15.00%
61.48
+0.89%
60.93
+1.24%
60.19
Retained Earnings
-71.61
-20.27%
-59.54
-34.25%
-44.35
-95.36%
-22.70
Total Equity Gross Minority Interest
-0.91
-147.24%
1.93
-88.33%
16.58
-55.77%
37.48
Total Capitalization
-0.91
-147.24%
1.93
-88.33%
16.58
-55.77%
37.48
Working Capital
-0.91
-147.24%
1.93
-88.33%
16.58
-55.77%
37.48
Invested Capital
-0.91
-147.24%
1.93
-88.33%
16.58
-55.77%
37.48
Net Tangible Assets
-0.91
-147.24%
1.93
-88.33%
16.58
-55.77%
37.48
Tangible Book Value
-0.91
-147.24%
1.93
-88.33%
16.58
-55.77%
37.48
Interest Payable
—
—
—
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-16.71
-69.61%
-9.85
+44.79%
-17.85
-22.72%
-14.54
Cash Flow From Continuing Operating Activities
-16.71
-69.61%
-9.85
+44.79%
-17.85
-22.72%
-14.54
Net Income From Continuing Operations
-12.07
+20.56%
-15.19
+29.84%
-21.65
-79.58%
-12.06
Stock Based Compensation
0.13
-75.27%
0.54
-26.88%
0.75
-23.53%
0.97
Operating Gains Losses
—
—
—
-0.06
Change In Working Capital
-4.78
-199.78%
4.79
+56.62%
3.06
+190.00%
-3.40
Change In Prepaid Assets
0.44
+131.96%
0.19
-90.67%
2.05
+175.66%
-2.71
Change In Payables And Accrued Expense
0.78
+29.35%
0.60
+160.36%
-0.99
-44.60%
-0.69
Change In Payable
—
—
—
-0.69
Change In Account Payable
—
—
—
-0.69
Change In Other Current Liabilities
-6.00
-250.00%
4.00
+100.00%
2.00
0.00
Financing Cash Flow
9.08
0.00
0.00
-100.00%
51.33
Cash Flow From Continuing Financing Activities
9.08
0.00
0.00
-100.00%
51.33
Net Issuance Payments Of Debt
—
—
0.00
+100.00%
-1.50
Issuance Of Debt
—
—
0.00
-100.00%
0.10
Repayment Of Debt
—
—
0.00
+100.00%
-1.60
Long Term Debt Issuance
—
—
—
0.10
Long Term Debt Payments
—
—
—
-1.60
Net Long Term Debt Issuance
—
—
—
-1.50
Short Term Debt Issuance
—
—
0.00
-100.00%
0.10
Short Term Debt Payments
—
—
0.00
+100.00%
-1.60
Net Short Term Debt Issuance
—
—
0.00
+100.00%
-1.50
Net Common Stock Issuance
6.32
0.00
0.00
-100.00%
58.02
Proceeds From Stock Option Exercised
2.77
0.00
—
—
Net Other Financing Charges
—
—
—
-5.19
Changes In Cash
-7.63
+22.58%
-9.85
+44.79%
-17.85
-148.51%
36.79
Beginning Cash Position
9.14
-51.87%
19.00
-48.44%
36.84
+67134.82%
0.05
End Cash Position
1.51
-83.45%
9.14
-51.87%
19.00
-48.44%
36.84
Free Cash Flow
-16.71
-69.61%
-9.85
+44.79%
-17.85
-22.72%
-14.54
Interest Paid Supplemental Data
—
—
0.00
-100.00%
0.36
Income Tax Paid Supplemental Data
—
—
0.00
0.00
Common Stock Issuance
6.32
0.00
0.00
-100.00%
58.02
Issuance Of Capital Stock
6.32
0.00
0.00
-100.00%
58.02
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category